Related Experiment Video
Updated: Sep 30, 2025

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders
Mena Farag1, Anish Bahra1,2
1The National Hospital for Neurology & Neurosurgery (NHNN), London, UK.
Abstract:
Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches. Many patients show a rapid therapeutic response to indomethacin, which is limited by intolerability. Etoricoxib and celecoxib, selective inhibitors of cyclo-oxygenase-2 (COX-2), spare gastroduodenal COX-1 activity and are less likely to cause gastrointestinal adverse effects than indomethacin. We report a case series of eight patients, seven who responded to etoricoxib and one patient who responded to celecoxib.
Related Concept Videos
Dose-Response Relationship: Potency and Efficacy
Therapeutic Index
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Analgesia and Pain Management

